局灶性乳腺症状女性初始超声后乳腺X线摄影的附加价值:系统综述
该系统综述纳入2002年1月至2024年2月PubMed检索的10项研究,评估乳腺X线摄影(MG)/数字乳腺断层合成(DBT)与靶向超声(US)在局灶性乳腺症状女性中的诊断性能。多数研究显示靶向US单独应用在相对年轻女性(30-39岁)中敏感度高(范围84.6-100%,最大研究报告98.3%)。MG的附加价值主要体现在确定乳腺癌范围和确认良性病变;当US提示良性发现且风险为低/平均时,MG的附加价值极小。
要点
- 靶向US单独应用在30-39岁局灶性乳腺症状女性中敏感度高(范围84.6-100%,最大研究报告98.3%)。
- MG/DBT的附加价值主要在于确定乳腺癌范围和从筛查角度确认良性异常。
- US提示良性发现且风险为低/平均时,MG附加价值极小;常规使用需权衡过度诊断、不必要活检和辐射暴露风险。
核心结论
- 靶向US是可靠的初始影像学方法,尤其在≤40岁年轻女性中;当US提示良性发现且风险为低/平均时,MG的附加价值极小,常规使用应权衡过度诊断、不必要活检和辐射暴露的风险。
研究设计与样本
- 系统综述,通过全面PubMed检索2002年1月至2024年2月发表的评估MG/DBT和靶向US在局灶性乳腺症状女性中诊断性能的文章,985项研究中10项符合纳入标准。
诊断标准与关键数值
- 靶向US单独应用在相对年轻女性(30-39岁)中敏感度范围为84.6-100%,最大研究报告98.3%。
临床应用与阅片要点
- 靶向US可作为局灶性乳腺症状女性(尤其≤40岁)的可靠初始影像学方法。
- 当US提示良性发现且风险为低/平均时,MG的附加价值极小。
- 临床与影像表现不一致时应始终促使进一步评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Breast cancer is the most common cancer among women, making accurate diagnostic imaging essential for evaluating focal breast complaints. Standard breast imaging includes mammography (MG), digital breast tomosynthesis (DBT), and targeted ultrasound (US). Little information is known about the added value of MG/DBT compared to targeted US alone in women with focal breast complaints. This review provides a systematic overview of the (relative) sensitivity of MG/DBT, next to the use of targeted US in women with focal breast complaints, while emphasizing the variations of the reported guidelines.
MATERIALS AND METHODS: A comprehensive PubMed search was conducted to identify articles published between January 2002 and February 2024 that assessed the diagnostic performance of MG/DBT and targeted US in women presenting with focal breast complaints.
RESULTS: Of the 985 identified studies, 10 met the inclusion criteria after full-text evaluation. Palpable lumps and focal pain are the more frequent symptoms. Most studies show a high sensitivity (range 84.6-100%, the largest study reported 98.3%) of targeted US alone in relatively young women (30-39 years). Mammograms show added value, particularly when it comes to determining the extent of breast cancer and when confirming a benign abnormality.
CONCLUSIONS: Targeted US is a reliable initial imaging modality, particularly in younger women (≤ 40). When the US suggests a benign finding in low/average-risk women, the added value of MG is minimal. Routine use should be weighed against the risk of overdiagnosis, unnecessary biopsies, and radiation exposure.
KEY POINTS: Question The best imaging strategy for women aged 30-40 with focal breast complaints is uncertain, and whether US alone suffices remains unresolved. Findings Initial targeted US shows high accuracy in this diagnostic setting, with MG/DBT adding value mainly in determination of tumor extent and from a screening perspective. Clinical relevance Using US as the primary imaging for women < 40 with focal breast symptoms may reduce MG, radiation, and discomfort, while maintaining cancer detection; however, any discordance between clinical and imaging findings should always prompt further evaluation.
引用
- Appelman L, Gil Quessep E, Veenendaal L, et al. Contribution of mammographic imaging after initial ultrasound in women with focal breast complaints-systematic review. Eur Radiol. 2025. PMID: 41417121. doi:10.1007/s00330-025-12218-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。